Increasing concerns have been raised surrounding the response of the Center for Disease Control and Prevention (CDC) towards the rise in hospitalized COVID patients – a number exceeding 10,000 individuals, reflecting a considerable 22% increase from the previous week. Critics are questioning the CDC’s approach towards combating disease spread, especially in light of increasing demands for individuals at severe risk to use masks indoors.
Discussion at the Healthcare Infection Control Practices Advisory Committee (HICPAC) meeting on August 22, 2023, was fraught with frustration. This meeting marked the third public comment period on the CDC’s proposed measures for updating isolation protocols, and responses varied – from worry to outright indignation. No public figure has expressed support for the proposed use of surgical masks in treating patients plagued with respiratory pathogens, or the assurance of safe ventilation in healthcare facilities. Furthermore, the draft embodying these proposals remains inaccessible to the public. The expressed disapproval from the masses has evolved from the HICPAC presentation on June 8, 2023, which detailed updates to the CDC’s isolation precaution guidelines, and the conspicuous lack of transparency and public involvement in the policy-making process.
Historically, HICPAC has maintained a low profile. However, its recent policies have incited backlash from patient advocacy groups and healthcare worker unions. Such entities have criticized their exposure to harmful pathogens, insisting on the flawed process of formulating recommendations.
Healthcare agencies’ submission to the use of surgical masks amongst practitioners treating airborne illnesses was met with incredulity. The absence of clear directives for universal N95 mask use was rationalized by an insufficiency of randomized controlled trials (RCTs) depicting a positive impact. Commentators at the meeting, however, pushed back, noting that other industrial sectors did not mandate RCTs before adopting safety measures. For instance, no one disputes the usage of respirators for firefighters or employees exposed to hazardous substances like asbestos and lead, regardless of the lack of supporting RCTs.
Healthcare officials further expressed skepticism towards the excessively heavy reliance on RCTs when crafting public health recommendations. This stems from the recognition that RCT protocols, while ideal for drug and therapeutic trials, may be less applicable to public health, given ethical restrictions on trial designs and inherent biases. A lack of extensive RCTs related to the isolation of colonized MRSA patients, for example, has significantly hindered the adoption of this practice in the private sector. This gap in practice has led to a noticeable disparity in performance between the Veterans Health Administration and private healthcare entities in preventing nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infections.
The HICPAC meeting also included calls for the inclusion of a wider array of specialists such as healthcare workers, safety professionals, industrial hygienists, ventilation engineers, and experts in respiratory protection. The current dominance of medical associations and societies on the committee was seen as creating an imbalanced perspective within the industry.
Interestingly, calls for universal precautionary measures with N95 masks and higher ventilation standards were also made, including covering patients in waiting areas. It was noted that with about half of SARS-CoV-2 transmissions originating from asymptomatic individuals, source control is crucial. Despite users being at potential risk of exposure through their eyes, masks can intercept a majority of viral particles originating from asymptomatic individuals, thereby reducing the risk of infection.
Economic arguments for more stringent policies were also raised. The cost of daily protective measures, as exemplified by pocket-friendly N95 masks, would be significantly lesser when compared to the financial loss caused by workforce absence or disability-induced unemployment. Drawing from data provided by the United States Department of Human Services, the cost of infectious disease is a staggering 9.6 million dollars per life lost – a price too steep to pay when less costly and effective preventive equipment is available.
However, what truly resonates is the potential loss of credibility associated with the CDC’s potential rollback on precautionary measures. In the midst of a pandemic, maintaining credibility is paramount. As one commentator aptly stated, ‘We need consistent messaging to educate the public about the true dangers of COVID and being disabled by long COVID.’ If the public cannot rely on CDC’s recommendations on masking and ventilation, their trust in vaccines is also likely to diminish. With attempts to downplay the dangers of SARS-CoV-2 and the urgency for necessary boosters, the CDC’s actions have left many feeling skeptical and underserved.
Source: https://www.infectioncontroltoday.com/view/as-covid-19-hospitalizations-increase-alarmingly-workers-patients-call-better-standards